Amgen to Acquire Abgenix for US$2.2 B
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 68 (Table of Contents)
Published: 6 Feb-2006
DOI: 10.3833/pdr.v2006.i68.568 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Amgen entered into an acquisition agreement to acquire Abgenix, thus strengthening its product portfolio in human therapeutic antibodies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS